Collaborative Research Group Core

协作研究核心（CR）是专门为非NEIDL研究者设计的网关 希望建立合作关系，使他们能够利用NEIDL的设施和能力， 他们的研究计划。原则要求是，所有拟议的研究都与使命有关 代表了外部调查人员和NEIDL研究之间的科学合作 工作人员，并由外部资助。例如，可以与调查人员开展研究合作 在生物防御和新发传染病区域卓越中心网络内， 研究（RCEs），或从区域生物防御实验室时，NEIDL的特殊设施可以 有用的应用。CR是NEIDL内部与私营和公共部门研究人员接口的单位， NEIDL可以为他们的研究项目以及国际研究组织增加价值， 印度医学研究理事会。CR核心将是NEIDL的第一个单位，以应对新的 以及世界上任何地方迅速出现的挑战，以安全可靠地研究 新出现的传染性病原体，以确定用于诊断、治疗药物的靶分子，或 候选疫苗因此，CR核心对于实现NEIDL的使命和目标至关重要。

The Collaborative Research Core (CR) is specifically designed to be a gateway for non-NEIDL investigators who wish to establish a collaboration that would allow them to utilize NEIDL facilities and capacities to further their research programs. The principle requirements are that all proposed research is relevant to the mission of the NEIDL, represents a scientific collaboration between the outside investigators and NEIDL research staff, and is externally funded. For example, research collaborations can be developed with investigators within the network of Regional Centers of Excellence for Biodefense and Emerging Infectious Diseases Research (RCEs), or from the Regional Biodefense Laboratory when the special facilities of NEIDL can be usefully applied. CR is the unit within NEIDL interfacing with private and public sector researchers when NEIDL can add value to their research programs, as well as with international research organizations, such as the Indian Council for Medical Research. The CR Core would be the first unit at NEIDL to respond to new and rapidly emerging challenges anywhere in the world, to safely and securely study basic pathogenesis of newly emerging infectious agents in order to identify target molecules for diagnostics, therapeutic drugs, or vaccine candidates. The CR Core is therefore central to achieving the mission and goals of the NEIDL.